FindTrial
Sign In

Evaluation Of Drug Usage In Cardiac Patients

A Prospective Study On Drug Utilization Evaluation In Coronary Artery Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/01/030356
Enrollment
164
Registered
2021-01-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I259- Chronic ischemic heart disease, unspecified

Interventions

Intervention1: Not applicable: Not applicable

Sponsors

Nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Hospitalized patients with coronary artery disease 1. Patients of either gender hospitalized during the study period.

Exclusion criteria

Exclusion criteria: 1. Patient admitted in ICU 2. Patients who canâ??t read and write. 3. Patients who are not willing to give consent. 4. Pregnant patients. 5. Patients with chronic kidney disease, malignant neoplasms or any other terminal diseases.

Design outcomes

Primary

MeasureTime frame
1.The better understanding regarding the drug utilization evaluation in coronary artery disease. Which also help in evaluating the patient outcomes and quality of life in coronary artery disease patients. 2. Assessing the incidence and factors influencing Drug Interactions Timepoint: single point—

Secondary

MeasureTime frame
1. The better understanding regarding the drug utilization evaluation in coronary artery disease. Which also help in evaluating the patient outcomes and quality of life in coronary artery disease patients. 2. Assessing the incidence and factors influencing Drug Interactions Timepoint: single point—

Countries

India

Contacts

Public ContactMr Akshay A

NGSM institute of pharmaceutical sciences

junojoel@nitte.edu.in9886367947

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026